Definition
A code set representing immunohistochemical stains used to assist in the diagnosis of lung cancer.
Representation
Data Type | Number |
---|---|
Format | N[N] |
Maximum character length | 2 |
Values
Value | Meaning | Start Date | End Date | |
---|---|---|---|---|
Permissible Values | 1 | Thyroid transcription factor-1 (TTF-1) | ||
2 | Cytokeratin 5 (CK5) | |||
3 | Cytokeratin 6 (CK6) | |||
4 | Cytokeratin 7 (CK7) | |||
5 | Cytokeratin 20 (CK20) | |||
6 | p53-related transcription factor p63 (p63) | |||
7 | Napsin | |||
88 | Other | |||
Supplementary Values | 97 | Not applicable-immunohistochemical staining not performed | ||
98 | Unknown if imunohistochemistry performed | |||
99 | Immunohistochemistry performed but stains not stated/inadequately described |
Comments
Guide for use:
Record the code for each immunohistochemical profile obtained to assist in the diagnosis of lung cancer.
Comments:
Thyroid transcription factor-1 and cytokeratin 7 and 20 can be useful, in conjunction with tumour morphology and clinical and radiological findings, to help to distinguish between primary and metastatic lung adenocarcinomas.
Cytokeratin 5/6 and p63 immunostaining is used by some pathologists to help to determine whether a tumour is a squamous or non-squamous type.
The majority (about 75%) of primary lung adenocarcinomas are CK7 positive, CK20 negative and TTF-1 positive and Napsin stains are positive in approximately 80% of of primary lung adenocarcinomas.References
Royal College of Pathologists of Australasia 2010. Lung cancer structured reporting protocol. 1st Edition (Version 1.0). Surry Hills, NSW: Royal College of Pathologists of Australasia
This content Based on Australian Institute of Health and Welfare material. Attribution provided as required under the AIHW CC-BY licence.
This content Based on Australian Institute of Health and Welfare material. Attribution provided as required under the AIHW CC-BY licence.
Related content
Relation | Count |
---|---|
Data Elements implementing this Value Domain | 1 |